CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −3,283 | $3.13 | $10K | 273,039 |
| 2025-06-02 | Florin Daniel P Director | Grant or award | +37,153 | 93,910 | ||
| 2025-06-02 | Mead Dana G Jr. Director | Grant or award | +37,153 | 99,714 | ||
| 2025-03-20 | French Glendon E. III Director | Sale 10b5-1 | −20,000 | $7.85 | $157K | 991,974 |
| 2025-03-03 | Joshi Mehul Chief Financial Officer & PAO | Sale | −14,384 | $7.12 | $102K | 113,986 |
| 2025-03-03 | Joshi Mehul Chief Financial Officer & PAO | Grant or award | +108,000 | 221,986 | ||
| 2025-03-03 | Williamson Steven S. PRESIDENT AND CEO | Sale | −27,689 | $7.14 | $198K | 194,342 |
| 2025-03-03 | Williamson Steven S. PRESIDENT AND CEO | Grant or award | +181,696 | 376,038 | ||
| 2025-03-03 | Williamson Steven S. PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +128,395 | 128,395 | ||
| 2025-03-03 | Lehman David Aaron GENERAL COUNSEL | Sale 10b5-1 | −669 | $7.14 | $5K | 197,182 |
| 2025-03-03 | Lehman David Aaron GENERAL COUNSEL | Sale 10b5-1 | −1,177 | $7.14 | $8K | 196,005 |
| 2025-03-03 | Lehman David Aaron GENERAL COUNSEL | Sale 10b5-1 | −4,490 | $7.14 | $32K | 191,515 |
| 2025-03-03 | Lehman David Aaron GENERAL COUNSEL | Sale 10b5-1 | −2,397 | $7.14 | $17K | 189,118 |
| 2025-03-03 | Lehman David Aaron GENERAL COUNSEL | Sale 10b5-1 | −13,622 | $7.97 | $109K | 175,496 |
| 2025-03-03 | Lehman David Aaron GENERAL COUNSEL | Grant or award 10b5-1 | +108,000 | 283,496 | ||
| 2025-03-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −520 | $7.12 | $4K | 290,537 |
| 2025-03-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −915 | $7.12 | $7K | 289,622 |
| 2025-03-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −2,327 | $7.14 | $17K | 287,295 |
| 2025-03-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −2,017 | $7.12 | $14K | 285,278 |
| 2025-03-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Grant or award | +108,000 | 393,278 |
Page 6 of 12 · 235 trades